Rubella Clinical Manifestations and Complications

Primary Clinical Manifestations

The Centers for Disease Control and Prevention (CDC) notes that rubella is characterized by nonspecific signs and symptoms including transient erythematous and sometimes pruritic rash, postauricular or suboccipital lymphadenopathy, arthralgia, and low-grade fever 1, 2
Lymphadenopathy primarily affects postauricular and suboccipital lymph nodes 1, 2
Low-grade fever is common 1, 3
Joint symptoms include transient polyarthralgia or polyarthritis, particularly common among adult women (up to 70% of cases) 2, 4

Subclinical infection occurs in 25-50% of rubella infections with no apparent symptoms 1, 3
The incubation period ranges from 12 to 23 days 1, 5
Patients are most contagious when the rash first appears, but the period of maximal communicability extends from a few days before to 7 days after rash onset 5
Differential diagnosis includes clinically similar exanthematous illnesses caused by parvovirus, adenoviruses, and enteroviruses 1, 2

Arthritis is more common in adults, especially women 2, 3
Central nervous system complications include encephalitis, which occurs at a rate of 1 per 6,000 cases, more likely to affect adults 1, 2
Thrombocytopenia occurs at a rate of 1 per 3,000 cases, more likely to affect children 1, 2

Pregnancy complications include miscarriages, stillbirths, and fetal anomalies, especially during the first trimester 1, 3
The classic triad of congenital defects includes cataracts and other eye defects 6, congenital heart defects (patent ductus arteriosus, peripheral pulmonary artery stenosis) 2, and sensorineural deafness 1
Other CRS manifestations include neurological (microcephaly, meningoencephalitis, mental retardation) 1, growth (intrauterine and postnatal growth retardation) 1, and additional findings (radiolucent bone defects, hepatosplenomegaly, thrombocytopenia, and purpuric skin lesions) 1, 4

Diagnostic challenges include clinical diagnosis of rubella being unreliable due to its variable presentation and similarity to other exanthematous illnesses 5
Laboratory confirmation relies on the presence of serum rubella IgG antibody 5
Risk assessment in pregnancy shows the risk of congenital defects is highest (up to 85%) when infection occurs during the first 8 weeks of gestation 1
Subclinical maternal infection can cause congenital malformations 1

Serologic testing involves a positive test for rubella-specific IgM antibody or significant rise in rubella IgG antibody between acute and convalescent sera 6